Swiss Rare Disease Registry (SRDR)
Launched by UNIVERSITY OF BERN · Dec 16, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Swiss Rare Disease Registry (SRDR) is a nationwide project in Switzerland aimed at gathering important information about rare diseases. This registry is designed for people of all ages who have been diagnosed with a rare disease or are suspected of having one. By collecting data on how these diseases are diagnosed and managed over time, the SRDR hopes to support research efforts and help improve care for patients. It will also connect patients, healthcare providers, and researchers, fostering better communication and collaboration.
If you or a family member has been diagnosed with a rare disease or there is a strong suspicion of one and you are receiving treatment in Switzerland, you may be eligible to participate in this registry. Joining the SRDR means you will contribute to a valuable resource that can help advance understanding and treatment of rare diseases. There are no exclusions based on health conditions, so if you meet the criteria, your participation would be welcomed. By taking part, you can help shape future research and improve outcomes for others facing similar health challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with a rare disease
- • High suspicion of a rare disease
- • Treated or living in Switzerland
- • Signed informed consent
- Exclusion Criteria:
- • None
About University Of Bern
The University of Bern, a leading research institution in Switzerland, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, the university fosters an environment where scientific inquiry and clinical application intersect. Its commitment to ethical standards and patient safety ensures that all trials are conducted with the highest integrity, striving to contribute valuable insights to the global medical community. The University of Bern actively engages in diverse therapeutic areas, aiming to translate research findings into tangible health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
St. Gallen, , Switzerland
Aarau, , Switzerland
Zurich, , Switzerland
Lausanne, , Switzerland
Zurich, , Switzerland
Basel, , Switzerland
Bern, , Switzerland
Geneva, , Switzerland
Lausanne, , Switzerland
Zurich, , Switzerland
Aarau, , Switzerland
Basel, , Switzerland
Basel, , Switzerland
Basel, , Switzerland
Bellinzona, , Switzerland
Bern, , Switzerland
Geneva, , Switzerland
Geneva, , Switzerland
Lausanne, , Switzerland
St. Gallen, , Switzerland
St.Gallen, , Switzerland
St.Gallen, , Switzerland
Zurich, , Switzerland
Zurich, , Switzerland
Zurich, , Switzerland
Patients applied
Trial Officials
Claudia E Kuehni, Prof. MD
Principal Investigator
Institute of Social and Preventive Medicine (ISPM)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials